The shares of Narayana Hrudayalaya jumped more than 15 percent on November 17 after the company released strong results for the second quarter of the ongoing financial year 2026.

Narayana Hrudayalaya on November 14 reported a consolidated net profit of Rs 258.37 crore for the July-September quarter of the financial year 2026. This marks a 30 percent year-on-year (YoY) rise from the Rs 198.63 crore net profit reported in the corresponding quarter of the previous financial year.

The firm's revenue from operations meanwhile grew over 20 percent YoY to Rs 1,643.79 crore in Q2 FY26, from Rs 1,366.68 crore in Q2 FY25. Expenses rose over 18 percent YoY to Rs 1,371 crore, while EBITDA increased more than 28 percent YoY to Rs 426.49 crore. EBITDA margin improved to 25.9 percent.

Speaking about the company's performance during the quarter, Narayana Hrudayalaya Managing Director and Group CEO Emmanuel Rupert said, "The second quarter of the fiscal year has delivered a strong performance after a steady start to the year. We are pleased to report the highest-ever revenue and profitability at both India and the Group level. The performance improvement in India is attributable to strong growth in domestic footfall and improvements in payor mix, along with positive traction from our Clinics outreach, resulting in the highest ever profitability margins. Our hospital business in Cayman continues to deliver robust performance, with the Insurance business showing strong growth, resulting in record revenues for the region. We are confident that the synergies between the hospital and insurance businesses will deliver steady growth going forward in the Cayman region."

"The domestic Integrated Care business continues to be on a strong growth path, with our clinics garnering sizeable footfalls across all locations, providing a positive thrust to the overall business. After a steady start, our domestic Insurance business has shown strong momentum this quarter and we expect to build on this further going forward. We will continue to invest in this business and are optimistic that it will be a significant driver of growth to the NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the year," he added.

The company is targeting an aggressive capital expenditure of over Rs 3,000 crore over the next 2-3 years towards addition of 2,000 planned beds along with the company's acquisition of UK-based Practice Plus Group Hospitals. The progress on these investments will be watched out for, ICICI Direct Research said in a note. "Improved profitability of India operations besides reigniting of Cayman performance bodes well for future expansion," the broking firm said.